RESUMEN
The subcutaneous injection of the methylxanthine derivative pentoxifylline (3,7, dimethyl-1-(5-oxo-hexyl)-xanthine) was able to induce, 3 h later, a significant reduction of benzodiazepine binding sites in rat cerebral cortex. When tested in vitro, pentoxifylline displaced 3H-flunitrazepam from specific binding sites in a competitive manner. For this effect pentoxifylline was about 10 times more potent than caffeine. When given in two daily injections for 5 days, pentoxifylline brought about a significant elevation in the number of cortical benzodiazepine binding sites. Neither acute nor chronic pentoxifylline treatment modified cortical muscarinic cholinergic binding sites. Pentoxifylline has negligible affinity for cortical muscarinic receptors in vitro. These results suggest that pentoxifylline is able to affect the cortical benzodiazepine receptors differentially, depending on time of drug administration.
Asunto(s)
Corteza Cerebral/metabolismo , Pentoxifilina/farmacología , Receptores de GABA-A/metabolismo , Receptores Muscarínicos/metabolismo , Teobromina/análogos & derivados , Animales , Unión Competitiva , Cafeína/metabolismo , Femenino , Flunitrazepam/metabolismo , Quinuclidinil Bencilato/metabolismo , Ratas , Ratas EndogámicasRESUMEN
In 3 000g-supernatants of rat pineal homogenates a single population of benzodiazepine (BZP) binding sites with dissociation constant= 97-102 nM and maximal number of sites= 6.5-9 pmoles/mg protein was detected by employing 3H-flunitrazepam (FNZP) as a radioligand. The following order of affinity for several BZP was found (Ki, nM): Ro 5-4864 (8), FNZP (99), clonazepam (7,900) Ro 15-1788 (10,000). Two weeks after bilateral superior cervical ganglionectomy (SCGx) a 18-28% reduction of site number without significant changes in affinity of 3H-FNZP binding was detectable in rat pineal glands. In pineal explants priorly incubated with 3H-norepinephrine, exposure to 0.1-10 microM of Ro 5-4864 or diazepam decreased significantly transmitter release elicited by 80 mM K+, whereas clonazepam did not affect it significantly. At 10 microM-concentrations, Ro 5-4864, diazepam or clonazepam increased pineal melatonin content of explants incubated for 6 h with the drug. In pineal explants of rats subjected to SCGx 14 days earlier, only 10 microM of Ro 5-4864 increased melatonin content significantly to about half of the percent increase detected in innervated glands. These results suggest that BZP decrease transmitter release from pineal sympathetic nerves by acting on peripheral BZP binding sites, an effect which is about 2 orders of magnitude greater than the postsynaptic stimulation of pineal melatonin synthesis.
Asunto(s)
Benzodiazepinas/farmacología , Melatonina/metabolismo , Norepinefrina/metabolismo , Glándula Pineal/metabolismo , Animales , Sitios de Unión , Técnicas In Vitro , Masculino , Ratas , Ratas EndogámicasRESUMEN
Pinealectomy of rats resulted in significant depression of benzodiazepine receptors (assessed by [(3)H]flunitrazepam binding) in cerebral cortex 3-14 days after surgery without affecting their affinity significantly. A single s.c. injection of melatonin (800 ?g/kg body wt) restored the depressed brain benzodiazepine receptor sites. Single melatonin injections (up to 1600 ?g/kg) to intact rats did not affect brain benzodiazepine binding when injected at either morning or evening hours. Daily melatonin treatment to intact rats for 5 days augmented benzodiazepine receptor density in brain (morning injections) or its dissociation constant (evening injections). Melatonin added in vitro to rat cerebral cortex membranes only slightly depressed [(3)H]flunitrazepam binding at 100 ?M concentrations. These results point out a link between pineal activity and benzodiazepine receptor function in rats. They also indicate that pharmacological doses of melatonin affect benzodiazepine binding sites in rat cerebral cortex.
RESUMEN
The subcutaneous injection of the methylxanthine derivative pentoxifylline (3,7, dimethyl-1-(5-oxo-hexyl)-xanthine) was able to induce, 3 h later, a significant reduction of benzodiazepine binding sites in rat cerebral cortex. When tested in vitro, pentoxifylline displaced 3H-flunitrazepam from specific binding sites in a competitive manner. For this effect pentoxifylline was about 10 times more potent than caffeine. When given in two daily injections for 5 days, pentoxifylline brought about a significant elevation in the number of cortical benzodiazepine binding sites. Neither acute nor chronic pentoxifylline treatment modified cortical muscarinic cholinergic binding sites. Pentoxifylline has negligible affinity for cortical muscarinic receptors in vitro. These results suggest that pentoxifylline is able to affect the cortical benzodiazepine receptors differentially, depending on time of drug administration.
RESUMEN
In 3 000g-supernatants of rat pineal homogenates a single population of benzodiazepine (BZP) binding sites with dissociation constant= 97-102 nM and maximal number of sites= 6.5-9 pmoles/mg protein was detected by employing 3H-flunitrazepam (FNZP) as a radioligand. The following order of affinity for several BZP was found (Ki, nM): Ro 5-4864 (8), FNZP (99), clonazepam (7,900) Ro 15-1788 (10,000). Two weeks after bilateral superior cervical ganglionectomy (SCGx) a 18-28
reduction of site number without significant changes in affinity of 3H-FNZP binding was detectable in rat pineal glands. In pineal explants priorly incubated with 3H-norepinephrine, exposure to 0.1-10 microM of Ro 5-4864 or diazepam decreased significantly transmitter release elicited by 80 mM K+, whereas clonazepam did not affect it significantly. At 10 microM-concentrations, Ro 5-4864, diazepam or clonazepam increased pineal melatonin content of explants incubated for 6 h with the drug. In pineal explants of rats subjected to SCGx 14 days earlier, only 10 microM of Ro 5-4864 increased melatonin content significantly to about half of the percent increase detected in innervated glands. These results suggest that BZP decrease transmitter release from pineal sympathetic nerves by acting on peripheral BZP binding sites, an effect which is about 2 orders of magnitude greater than the postsynaptic stimulation of pineal melatonin synthesis.
Asunto(s)
Animales , Ratas , Benzodiazepinas , Corteza Cerebral , Receptores de GABA-A , Unión CompetitivaAsunto(s)
Animales , Ratas , Benzodiazepinas , Corteza Cerebral , Receptores de GABA-A , Unión CompetitivaRESUMEN
This article discusses the experimental evidence which suggests that the pineal gland and its innervating neurons are useful paradigms for the study of neuroendocrine integrative processes. The obtained results can be summarized as follows: 1) existence of putative receptors for various hormones (estradiol, testosterone, 5 alpha-dihydrotestosterone, progesterone, prolactin) in the mammalian pineal gland; (2) steroid metabolic pattern in the pineal gland resembling other brain areas involved in gonadotrophic regulation; (3) control of pineal estrophilic and androphilic receptors by adrenergic transmitter through beta-adrenergic receptors and at a translational level; (4) denervation supersensitivity of hormone receptors to neurotransmitter; (5) modification of neuronal activity by hormone treatment at ganglionic and preganglionic sites of action; (6) estrophilic binding sites in ganglia; (7) correlation of pineal responsiveness to hormones with activity of sympathetic nerves; (8) modification by hormones of pineal beta-adrenergic mechanisms; (9) dissociation of hormone effects on the pineal gland in those mediated or modulated by changes in afferent neuronal activity and those relatively unaffected by denervation. Collectively these data indicate that neuroendocrine, endocrine-neural and endocrine-endocrine transducing processes occur in the pinealocytes and superior cervical ganglia.
Asunto(s)
Neurotransmisores/fisiología , Glándula Pineal/fisiología , Animales , Bovinos , Ritmo Circadiano , Cricetinae , Depresión Química , Estro , Femenino , Ganglios Simpáticos/fisiología , Hormonas Esteroides Gonadales/fisiología , Humanos , Luz , Masculino , Melatonina/fisiología , Modelos Biológicos , Ovulación , Glándula Pineal/metabolismo , Embarazo , Ratas , Receptores de Superficie Celular/metabolismo , Sistema Nervioso Simpático/fisiologíaRESUMEN
This article discusses the experimental evidence which suggests that the pineal gland and its innervating neurons are useful paradigms for the study of neuroendocrine integrative processes. The obtained results can be summarized as follows: 1) existence of putative receptors for various hormones (estradiol, testosterone, 5 alpha-dihydrotestosterone, progesterone, prolactin) in the mammalian pineal gland; (2) steroid metabolic pattern in the pineal gland resembling other brain areas involved in gonadotrophic regulation; (3) control of pineal estrophilic and androphilic receptors by adrenergic transmitter through beta-adrenergic receptors and at a translational level; (4) denervation supersensitivity of hormone receptors to neurotransmitter; (5) modification of neuronal activity by hormone treatment at ganglionic and preganglionic sites of action; (6) estrophilic binding sites in ganglia; (7) correlation of pineal responsiveness to hormones with activity of sympathetic nerves; (8) modification by hormones of pineal beta-adrenergic mechanisms; (9) dissociation of hormone effects on the pineal gland in those mediated or modulated by changes in afferent neuronal activity and those relatively unaffected by denervation. Collectively these data indicate that neuroendocrine, endocrine-neural and endocrine-endocrine transducing processes occur in the pinealocytes and superior cervical ganglia.
RESUMEN
This article discusses the experimental evidence which suggests that the pineal gland and its innervating neurons are useful paradigms for the study of neuroendocrine integrative processes. The obtained results can be summarized as follows: 1) existence of putative receptors for various hormones (estradiol, testosterone, 5 alpha-dihydrotestosterone, progesterone, prolactin) in the mammalian pineal gland; (2) steroid metabolic pattern in the pineal gland resembling other brain areas involved in gonadotrophic regulation; (3) control of pineal estrophilic and androphilic receptors by adrenergic transmitter through beta-adrenergic receptors and at a translational level; (4) denervation supersensitivity of hormone receptors to neurotransmitter; (5) modification of neuronal activity by hormone treatment at ganglionic and preganglionic sites of action; (6) estrophilic binding sites in ganglia; (7) correlation of pineal responsiveness to hormones with activity of sympathetic nerves; (8) modification by hormones of pineal beta-adrenergic mechanisms; (9) dissociation of hormone effects on the pineal gland in those mediated or modulated by changes in afferent neuronal activity and those relatively unaffected by denervation. Collectively these data indicate that neuroendocrine, endocrine-neural and endocrine-endocrine transducing processes occur in the pinealocytes and superior cervical ganglia.